The use of SGC STIMULATORS, GC Activators, alone and combinations with PDE5 Inhibitors for the treatment of digital ulcers (DU) concomitant with systemic sclerosis (SSC).
VAKALOPOULOS, Alexandros,FOLLMANN, Markus,HIRTH-DIETRICH, Claudia,SANDNER, Peter,STASCH, Johannes-Peter,HAHN, Michael
申请号：
CL2017002765
公开号：
CL2017002765A1
申请日:
2017.11.02
申请国别(地区):
CL
年份:
2018
代理人:
摘要：
<； p >； use of SGC Activators SGC STIMULATORS, alone or in combination with PDE5 Inhibitors for the Prevention and Healing of digital ulcers that are concomitant with fibrotic diseases.Such as Scleroderma and systemic sclerosis. <； / p >；<；p>；Uso de estimuladores sGC, activadores sGC solos o en combinació；n con inhibidores PDE5 para la prevenció；n y cicatrizació；n de ú；lceras digitales que son concomitantes con enfermedades fibró；ticas, tal como esclerosis sisté；mica y esclerodermia.<；/p>；
